Re-assessment of the IAB following joint referral by the Ministry of Health, the Social Security Directorate and the Directorate General for Health Services on 10 October 2013, and in accordance with article R 163-19 of the French Social Security Code.
Clinical Benefit
Insufficient
the actual benefit of ETHYOL in the prevention of acute and late xerostomia in combination with standard fractionated radiotherapy in ENT cancers is insufficient for reimbursement by National Health Insurance
Clinical Added Value
Not applicable
As the actual benefit is insufficient, an assessment of the improvement in actual benefit brought about by ETHYOL is not appropriate.
Listen
